My Department is in ongoing consultation with the IDA regarding the factory closure at Tosara Pharma Ltd. in Baldoyle.
Tosara has informed my Department, through IDA Ireland, that it is on track to cease activity in the plant in November 2022 and the facility will be decommissioned in Q1 2023. From my understanding, Tosara intends to sell the site as is and marketing materials will be released in due course by its Agent to both IDA Ireland and Enterprise Ireland to assist in promoting the facility across its network.
The Department of Social Protection is aware of the situation, and it will ensure all necessary provisions are in place to support the over 100 affected employees when the closure happens. These supports will include welfare entitlements, help with job search and educational/upskilling opportunities.
I have also been made aware that Teva facilitated an educational programme which included diplomas, degrees, and green/yellow belt training, all conducted by Skillnet via a budget from Teva. This support is ongoing as Teva plan to roll out outplacement services in July 2022, providing support for employees for interviews and CV writing.
Tosara have confirmed to the IDA that the redundancy packaged being offered to its staff is above statutory levels. The package has been discussed with all staff, with the terms of the redundancy being part of negotiations over the past number of months.
